Guangdong Jiaying Pharmaceutical Co., Ltd (002198.SZ)
CNY 7.43
(-9.06%)
CNY 7.43
(-9.06%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 84.6 Million CNY | 2.81% |
| 2022 | 82.28 Million CNY | 12.17% |
| 2021 | 73.35 Million CNY | 0.77% |
| 2020 | 72.79 Million CNY | -5.17% |
| 2019 | 76.77 Million CNY | 7.06% |
| 2018 | 71.7 Million CNY | 13.22% |
| 2017 | 63.33 Million CNY | 31.48% |
| 2016 | 48.17 Million CNY | 1.69% |
| 2015 | 47.36 Million CNY | -21.0% |
| 2014 | 59.96 Million CNY | 7.83% |
| 2013 | 55.6 Million CNY | 127.46% |
| 2012 | 24.44 Million CNY | 1.36% |
| 2011 | 24.11 Million CNY | 45.98% |
| 2010 | 16.52 Million CNY | 97.41% |
| 2009 | 8.36 Million CNY | 8.66% |
| 2008 | 7.7 Million CNY | -4.14% |
| 2007 | 8.03 Million CNY | 20.73% |
| 2006 | 6.65 Million CNY | -16.07% |
| 2005 | 7.92 Million CNY | -25.07% |
| 2004 | 10.58 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 97.43 Million CNY | 8.32% |
| 2024 Q1 | 89.94 Million CNY | 6.32% |
| 2024 Q3 | 87.15 Million CNY | -10.54% |
| 2023 FY | 84.6 Million CNY | 2.81% |
| 2023 Q4 | 84.6 Million CNY | -8.08% |
| 2023 Q1 | 83.43 Million CNY | 1.4% |
| 2023 Q2 | 80.99 Million CNY | -2.93% |
| 2023 Q3 | 92.04 Million CNY | 13.64% |
| 2022 Q2 | 86.72 Million CNY | 9.52% |
| 2022 Q1 | 79.18 Million CNY | 7.95% |
| 2022 Q3 | 78.07 Million CNY | -9.98% |
| 2022 Q4 | 82.28 Million CNY | 5.4% |
| 2022 FY | 82.28 Million CNY | 12.17% |
| 2021 Q4 | 73.35 Million CNY | -5.55% |
| 2021 Q3 | 77.66 Million CNY | -6.63% |
| 2021 Q2 | 83.18 Million CNY | 11.37% |
| 2021 Q1 | 74.68 Million CNY | 2.59% |
| 2021 FY | 73.35 Million CNY | 0.77% |
| 2020 Q4 | 72.79 Million CNY | -2.03% |
| 2020 FY | 72.79 Million CNY | -5.17% |
| 2020 Q1 | 77.45 Million CNY | 0.89% |
| 2020 Q2 | 81.88 Million CNY | 5.72% |
| 2020 Q3 | 74.3 Million CNY | -9.26% |
| 2019 Q1 | 78.83 Million CNY | 9.94% |
| 2019 FY | 76.77 Million CNY | 7.06% |
| 2019 Q3 | 75.3 Million CNY | -10.56% |
| 2019 Q4 | 76.77 Million CNY | 1.95% |
| 2019 Q2 | 84.19 Million CNY | 6.8% |
| 2018 Q3 | 72.6 Million CNY | -7.23% |
| 2018 Q1 | 64.43 Million CNY | 1.74% |
| 2018 FY | 71.7 Million CNY | 13.22% |
| 2018 Q2 | 78.26 Million CNY | 21.46% |
| 2018 Q4 | 71.7 Million CNY | -1.24% |
| 2017 Q3 | 68.66 Million CNY | 14.85% |
| 2017 Q2 | 59.78 Million CNY | 6.44% |
| 2017 Q1 | 56.17 Million CNY | 16.61% |
| 2017 Q4 | 63.33 Million CNY | -7.77% |
| 2017 FY | 63.33 Million CNY | 31.48% |
| 2016 Q3 | 54.19 Million CNY | -1.8% |
| 2016 Q4 | 48.17 Million CNY | -11.11% |
| 2016 Q1 | 52.11 Million CNY | 10.01% |
| 2016 FY | 48.17 Million CNY | 1.69% |
| 2016 Q2 | 55.18 Million CNY | 5.89% |
| 2015 Q2 | 53.06 Million CNY | -5.88% |
| 2015 FY | 47.36 Million CNY | -21.0% |
| 2015 Q4 | 47.36 Million CNY | -5.2% |
| 2015 Q3 | 49.96 Million CNY | -5.83% |
| 2015 Q1 | 56.37 Million CNY | -5.98% |
| 2014 Q2 | 55.66 Million CNY | 9.02% |
| 2014 Q3 | 60.04 Million CNY | 7.87% |
| 2014 Q4 | 59.96 Million CNY | -0.14% |
| 2014 Q1 | 51.06 Million CNY | -8.17% |
| 2014 FY | 59.96 Million CNY | 7.83% |
| 2013 Q3 | 37.55 Million CNY | 11.64% |
| 2013 Q4 | 55.6 Million CNY | 48.05% |
| 2013 Q1 | 24.78 Million CNY | 1.4% |
| 2013 FY | 55.6 Million CNY | 127.46% |
| 2013 Q2 | 33.64 Million CNY | 35.71% |
| 2012 Q3 | 25.91 Million CNY | -0.05% |
| 2012 FY | 24.44 Million CNY | 1.36% |
| 2012 Q4 | 24.44 Million CNY | -5.66% |
| 2012 Q2 | 25.92 Million CNY | 6.07% |
| 2012 Q1 | 24.44 Million CNY | 1.35% |
| 2011 Q3 | 23.94 Million CNY | 10.37% |
| 2011 FY | 24.11 Million CNY | 45.98% |
| 2011 Q4 | 24.11 Million CNY | 0.72% |
| 2011 Q1 | 14.32 Million CNY | -13.31% |
| 2011 Q2 | 21.69 Million CNY | 51.47% |
| 2010 Q1 | 11.56 Million CNY | 38.22% |
| 2010 Q4 | 16.52 Million CNY | 1.32% |
| 2010 Q3 | 16.3 Million CNY | 34.79% |
| 2010 Q2 | 12.09 Million CNY | 4.58% |
| 2010 FY | 16.52 Million CNY | 97.41% |
| 2009 Q4 | 8.36 Million CNY | 4.91% |
| 2009 Q3 | 7.97 Million CNY | -21.22% |
| 2009 Q2 | 10.12 Million CNY | 23.34% |
| 2009 Q1 | 8.21 Million CNY | 6.61% |
| 2009 FY | 8.36 Million CNY | 8.66% |
| 2008 FY | 7.7 Million CNY | -4.14% |
| 2008 Q1 | 7.39 Million CNY | -7.92% |
| 2008 Q2 | 8.64 Million CNY | 16.91% |
| 2008 Q3 | 9 Million CNY | 4.1% |
| 2008 Q4 | 7.7 Million CNY | -14.46% |
| 2007 Q4 | 8.03 Million CNY | 11.58% |
| 2007 Q2 | 7.32 Million CNY | 0.0% |
| 2007 FY | 8.03 Million CNY | 20.73% |
| 2007 Q3 | 7.2 Million CNY | -1.74% |
| 2006 FY | 6.65 Million CNY | -16.07% |
| 2006 Q4 | 6.65 Million CNY | 0.0% |
| 2005 FY | 7.92 Million CNY | -25.07% |
| 2004 FY | 10.58 Million CNY | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Zhejiang Int'l Group Co.,Ltd. | 3.57 Billion CNY | 97.631% |
| Zhejiang Zhenyuan Share Co., Ltd. | 679.41 Million CNY | 87.548% |
| Hunan Jingfeng Pharmaceutical Co.,Ltd. | 64.57 Million CNY | -31.005% |
| Hubei Guangji Pharmaceutical Co., Ltd. | 298.99 Million CNY | 71.705% |
| Yifan Pharmaceutical Co., Ltd. | 928.6 Million CNY | 90.89% |
| Sichuan Kelun Pharmaceutical Co., Ltd. | 3.83 Billion CNY | 97.797% |
| Chongqing Lummy Pharmaceutical Co., Ltd. | 170.99 Million CNY | 50.525% |
| Boai NKY Medical Holdings Ltd. | 309.8 Million CNY | 72.692% |
| Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. | 59.03 Million CNY | -43.299% |